Vertex Pharmaceuticals | Betriebsaufwand

Aktienkurs
463.87
Täglich Wechseln
2.63 0.57%
Monatlich
2.02%
Jährlich
0.28%
Q1 Prognose
463.25




Betriebsaufwand Veränderung Datum
AbbVie USD 10.81B 13.45B 2025-12
Acadia Pharmaceuticals USD 242.88M 10.68M 2025-09
Agios Pharmaceuticals USD 141.54M 11.8M 2025-12
Alnylam Pharmaceuticals USD 965.32M 84.27M 2025-12
Amgen USD 5.9B 773M 2025-12
Arrowhead Research USD 223.22M 10.86M 2025-12
Biogen USD 1.88B 81.4M 2025-09
BioMarin Pharmaceutical USD 807.82M 259.3M 2025-09
Bristol-Myers Squibb USD 8.3B 10.25B 2025-12
Gilead Sciences USD 4.96B 707M 2025-12
Incyte USD 1.12B 3.53B 2025-12
Insmed USD 403.69M 42.4M 2025-09
Ionis Pharmaceuticals USD 316.9M 4.69M 2025-09
J&J USD 18.97B 2.38B 2025-12
Merck USD 10.16B 558M 2025-12
Moderna USD 1.28B 232M 2025-09
Neurocrine Biosciences USD 577.6M 22M 2025-12
Novartis USD 9.86B 115M 2025-09
Pfizer USD 12.91B 79.89B 2025-12
PTC Therapeutics USD 207.52M 6.21M 2025-09
Puma Biotechnology USD 49.26M 3.2M 2024-06
Regeneron Pharmaceuticals USD 2.99B 27.97B 2025-12
Roche Holding CHF 21.01B 10.84B 2025-12
Sangamo BioSciences USD 33.87M 12.89M 2024-06
Sanofi EUR 10.51B 1.21B 2025-12
Sarepta Therapeutics USD 462.23M 33.28M 2025-09
Ultragenyx Pharmaceutical USD 330.82M 56.44M 2025-09
United Therapeutics USD 6.59B 6.07B 2025-09
Vertex Pharmaceuticals USD 1.84B 27.1M 2025-09


Vertex Pharmaceuticals Betriebsaufwand - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Feb 2026.